Mukul Agrawal Portfolio: Top Stock Holdings and Sectors
Mukul Agrawal Portfolio: Top Stock Holdings and Sectors
Mukul Agrawal’s publicly disclosed equity portfolio is worth Rs 7,266.01 crore, spread across 74 stocks, according to Trendlyne’s Superstar Portfolio tracker. That is a large, highly diversified holding pattern, and his portfolio value has climbed 27.28% over the latest quarter tracked.
If you have come across his name while researching Indian stock market investors, this article breaks down exactly what is disclosed, what it means, and how to think about it without copying trades blindly.
Who Is Mukul Agrawal as an Investor
Mukul Agrawal is one of the individual investors tracked under Trendlyne’s Superstar Portfolio feature. This tracker follows investors, HNIs, and fund managers who cross the 1% shareholding threshold in listed Indian companies, a level that triggers mandatory disclosure under stock exchange rules.
His portfolio stands out for one clear reason: breadth. With 74 disclosed stocks, this is one of the more spread out portfolios among tracked investors, suggesting a style built on diversification and active portfolio churn rather than concentrated conviction bets.
How Big Is the Portfolio and How Has It Moved
The disclosed portfolio value is Rs 7,266.01 crore as of the latest quarterly filing. Over the quarter, that value rose 27.28%, which reflects both stock price movement and any new positions added or exited during the period.
It is worth remembering that this number only reflects holdings above the 1% disclosure threshold. Any position sized below that level in a given company simply will not show up here, so the real portfolio could look somewhat different in composition.
Sector Allocation: Where the Money Is Concentrated
Three sectors dominate the disclosed holdings:
| Sector | Weight |
|---|---|
| Pharmaceuticals & Biotechnology | 18.79% |
| General Industrials | 11.69% |
| Banking and Finance | 10.51% |
Pharma and biotech make up the single largest chunk at nearly 19%, followed by general industrials and banking and finance. Together these three sectors account for close to 41% of the tracked portfolio, with the remaining spread across many other industries given the 74-stock count.
A pharma-heavy tilt combined with industrial and financial exposure often signals a barbell approach: betting on both defensive, research-driven businesses and cyclical, economy-linked ones at the same time.
Top Holdings in the Portfolio
The three largest disclosed positions are:
- Neuland Laboratories – Rs 678.56 crore
- Radico Khaitan – Rs 487.91 crore
- ASM Technologies – Rs 464.08 crore
Neuland Laboratories is a pharmaceutical company known for active pharmaceutical ingredient (API) manufacturing and custom manufacturing solutions for global drug makers. Radico Khaitan is one of India’s well known spirits and liquor companies, with a long history in the branded alcoholic beverages business. ASM Technologies operates in engineering and IT services.
These three names alone account for a meaningful share of the total disclosed value, even though the portfolio has 74 stocks in total, which tells you that despite the wide spread, a handful of positions still carry outsized weight.
Recent Buying Activity
The latest disclosed purchases show interest in smaller, less widely known names:
- E to E Transportation & Logistics (E2E Rail): increased by 13.94%
- Siyaram Recycling Industries: increased by 9.64%
- Osel Devices: increased by 7.56%
These look like fresh or expanded positions in logistics, recycling, and technology-adjacent businesses. The percentage figures reflect the change in stake or holding disclosed in the latest filing, not the absolute rupee value invested.
Recent Selling Activity
On the exit side, the disclosed trims are relatively small in percentage terms:
- InfoBeans Technologies: reduced by 0.81%
- Autoriders International: reduced by 0.34%
- Zota Healthcare: reduced by 0.18%
These look more like modest trimming than full exits, which fits with a high-turnover, actively managed style rather than one built around long-term buy-and-hold conviction.
What This Portfolio Style Suggests
A 74-stock portfolio with regular buying and selling activity across small and mid-sized companies points to an active, research-intensive approach. This is different from investors who hold a handful of large positions for years.
The pharma tilt combined with industrial and financial services exposure suggests a search for growth across multiple themes rather than a single sector conviction. It also means the portfolio is likely to see more frequent quarterly changes than a concentrated one.
Understanding Superstar Portfolio Data: A Quick Primer
Trendlyne’s Superstar Portfolio tracker pulls from shareholding disclosures that Indian companies file with stock exchanges once an individual or entity crosses 1% ownership in that company. This is a regulatory disclosure requirement, not a voluntary one.
A few things to keep in mind:
- Quarterly lag: Data reflects the most recent quarter’s shareholding pattern filings, so it is never real time.
- Partial picture: Only stakes above 1% show up, so smaller positions and other asset classes (bonds, real estate, unlisted shares) are invisible here.
- No entry price or timing: You see the current stake, not when it was bought or at what price, so you cannot calculate the investor’s actual returns from this alone.
- Not investment advice: This data is a research starting point to understand what sectors and companies an investor is paying attention to, not a signal to copy their trades.
How to Use This Information Sensibly
If you want to study Mukul Agrawal’s portfolio further, treat it as a lens into where informed money may be looking, not a shortcut to returns. Use it alongside your own research into company fundamentals, valuations, and your personal risk appetite.
Diversification across 74 stocks also means individual position sizing matters less to overall portfolio outcomes than it would in a concentrated portfolio, so weighting decisions here reflect a different risk approach than a 5 or 10 stock portfolio would.
Why Sector Concentration Still Matters Even in a Diversified Portfolio
It might seem like a 74-stock portfolio removes sector risk entirely, but that is not quite true. When close to 41% of disclosed value sits in just three sectors, pharma, general industrials, and banking and finance, the portfolio still carries meaningful exposure to how those industries perform as a group.
If pharma stocks face regulatory pressure, pricing changes, or a slowdown in export demand, a large chunk of this portfolio could feel it at once, even though the stock count looks spread out. The same logic applies to industrial cycles and banking sector credit conditions.
This is a useful reminder for retail investors building their own portfolios: counting the number of stocks you hold is not the same as measuring true diversification. Two portfolios with 74 stocks each can carry very different risk profiles depending on how concentrated the sector and industry exposure actually is underneath the surface.
Frequently Asked Questions
How many stocks does Mukul Agrawal hold according to Superstar Portfolio data?
Trendlyne’s tracker discloses 74 stocks in his portfolio as of the latest quarterly filing, making it one of the more diversified portfolios tracked under the Superstar Portfolio feature.
What is Mukul Agrawal’s top holding by value?
Neuland Laboratories is the largest disclosed holding at Rs 678.56 crore, followed by Radico Khaitan and ASM Technologies.
Which sector does Mukul Agrawal favor the most?
Pharmaceuticals and biotechnology is the largest sector allocation at 18.79%, ahead of general industrials at 11.69% and banking and finance at 10.51%.
Is Superstar Portfolio data updated in real time?
No. It is based on quarterly shareholding disclosures that companies file once an investor crosses the 1% ownership threshold, so there is always a reporting lag.
Should I copy Mukul Agrawal’s stock picks directly?
No. This data shows current disclosed positions, not entry price, timing, or the investor’s full financial picture. Use it as a starting point for your own research, not a trading signal.
Key Takeaways
- Mukul Agrawal’s disclosed portfolio is worth Rs 7,266.01 crore across 74 stocks, up 27.28% over the latest quarter.
- Top sector exposure is pharmaceuticals and biotechnology (18.79%), followed by general industrials (11.69%) and banking and finance (10.51%).
- Top three holdings are Neuland Laboratories, Radico Khaitan, and ASM Technologies.
- Recent buys include E2E Rail, Siyaram Recycling Industries, and Osel Devices.
- Recent trims include InfoBeans Technologies, Autoriders International, and Zota Healthcare.
- The 74-stock spread suggests an active, diversified, high-turnover investing style.
- Superstar Portfolio data reflects only disclosed 1% plus stakes on a quarterly lag, so it is a research tool, not investment advice.
